BioEquity Europe 2026

BioEquity Europe 2026 se celebrarà en format presencial a Praga, República Txeca, del 4 al 6 de maig de 2026 i, en línea els dies 12 i 13 de maig de 2026 per a la col·laboració digital. A més, l’esdeveniment serà organitzat per BioCentury i EBD Group.

BioEquity Europe 2026 will take place in person in Prague, Czech Republic, from May 4 to 6, 2026, and online on May 12 and 13, 2026 for digital partnering. Additionally, the event will be organized by BioCentury and EBD Group.

In a global context marked by geopolitical shifts and a reconfiguration of capital, data, and talent flows, the biotechnology industry is entering a new phase of adaptation and challenge. BioEquity Europe 2026 will explore how European biotech can take on a leadership role, as well as how industry leaders might collaborate, scale, and evolve in response to this changing landscape.

With more than 25 years of experience, this event has established itself as the leading meeting point for CEOs and investors, and stands out as the forum attracting the most venture capital within the European biotech scene.

• Join the debate on what’s next for the European biotech ecosystem.
• Meet VCs, CEOs, and BD&L leaders in an intimate setting designed for networking and strategic discussion.
• Discover over 100 emerging biotech companies selected for the Presenting Company Track.
• Schedule partnering meetings with investors and BD&L executives from leading pharma companies.
• Dive into European biotech trends with an exclusive conference report from Insights Partner McKinsey & Company.